{"id":"https://openalex.org/W2999863306","doi":"https://doi.org/10.1021/acs.jmedchem.9b01365","title":"Dose Predictions for Drug Design","display_name":"Dose Predictions for Drug Design","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-08","ids":{"openalex":"https://openalex.org/W2999863306","doi":"https://doi.org/10.1021/acs.jmedchem.9b01365","mag":"2999863306","pmid":"https://pubmed.ncbi.nlm.nih.gov/31913040"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.9b01365","doi":"https://doi.org/10.1021/acs.jmedchem.9b01365","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.9b01365","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2999863306"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013278963","display_name":"Tristan S. Maurer","orcid":"https://orcid.org/0009-0007-2994-1954","observed_orcids":["https://orcid.org/0009-0007-2994-1954"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tristan S. Maurer","raw_affiliation_strings":["Medicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002542670","display_name":"Dennis A. Smith","orcid":"https://orcid.org/0009-0001-7112-7661","observed_orcids":["https://orcid.org/0009-0001-7112-7661"]},"institutions":[{"id":"https://openalex.org/I4405252915","display_name":"Marine Ecosystems and oRganisms reSEArch Lab","ror":"https://ror.org/0041cxe63","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4405252915","https://openalex.org/I98702875"]},{"id":"https://openalex.org/I4405265350","display_name":"Laboratoire de gestion et des transitions organisationnelles","ror":"https://ror.org/04j4x7k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4405258862","https://openalex.org/I4405265350"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dennis Smith","raw_affiliation_strings":["4 The Maltings, Walmer, Kent CT14 7AR, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4 The Maltings, Walmer, Kent CT14 7AR, U.K","institution_ids":["https://openalex.org/I4405252915","https://openalex.org/I4405265350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022309341","display_name":"Kevin C. Beaumont","orcid":"https://orcid.org/0000-0001-8721-6450","observed_orcids":["https://orcid.org/0000-0001-8721-6450"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kevin Beaumont","raw_affiliation_strings":["Medicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine Design, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100631126","display_name":"Li Di","orcid":"https://orcid.org/0000-0001-6117-9022","observed_orcids":["https://orcid.org/0000-0001-6117-9022"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Li Di","raw_affiliation_strings":["Medicine Design, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States"],"raw_orcid":"https://orcid.org/0000-0001-6117-9022","affiliations":[{"raw_affiliation_string":"Medicine Design, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100631126"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":2.4662,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":{"value":0.90940122,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"63","issue":"12","first_page":"6423","last_page":"6435"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dose-prediction","display_name":"dose prediction","score":0.9860000014305115},{"id":"https://openalex.org/keywords/drug-design","display_name":"drug design","score":0.703000009059906},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.3959999978542328},{"id":"https://openalex.org/keywords/lead-optimization","display_name":"lead optimization","score":0.6370000243186951},{"id":"https://openalex.org/keywords/early-drug-discovery","display_name":"early drug discovery","score":0.6809999942779541},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.36399999260902405},{"id":"https://openalex.org/keywords/clinical-drug-development","display_name":"clinical development","score":0.41999998688697815},{"id":"https://openalex.org/keywords/candidate-nomination","display_name":"candidate nomination","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.857099175453186},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6100921034812927},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4413910508155823},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.9b01365","doi":"https://doi.org/10.1021/acs.jmedchem.9b01365","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.9b01365","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:31913040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31913040","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W1212001129","https://openalex.org/W1581793270","https://openalex.org/W1895993106","https://openalex.org/W1946715106","https://openalex.org/W1964622173","https://openalex.org/W1967221084","https://openalex.org/W1969780974","https://openalex.org/W1972882218","https://openalex.org/W1979020366","https://openalex.org/W1979392432","https://openalex.org/W1979991882","https://openalex.org/W1980156644","https://openalex.org/W1982162055","https://openalex.org/W1982975095","https://openalex.org/W1990520277","https://openalex.org/W1996100382","https://openalex.org/W2030913249","https://openalex.org/W2035736739","https://openalex.org/W2035845553","https://openalex.org/W2037690163","https://openalex.org/W2040624495","https://openalex.org/W2049175881","https://openalex.org/W2056872819","https://openalex.org/W2058298068","https://openalex.org/W2066259921","https://openalex.org/W2066482395","https://openalex.org/W2070858338","https://openalex.org/W2074631079","https://openalex.org/W2080843536","https://openalex.org/W2086121036","https://openalex.org/W2088206004","https://openalex.org/W2088874961","https://openalex.org/W2104338741","https://openalex.org/W2113717321","https://openalex.org/W2117022661","https://openalex.org/W2124004413","https://openalex.org/W2124158971","https://openalex.org/W2128540492","https://openalex.org/W2162548536","https://openalex.org/W2166550586","https://openalex.org/W2230967700","https://openalex.org/W2231789276","https://openalex.org/W2263138261","https://openalex.org/W2270318974","https://openalex.org/W2290466312","https://openalex.org/W2304507804","https://openalex.org/W2461975652","https://openalex.org/W2530162117","https://openalex.org/W2556015214","https://openalex.org/W2592821463","https://openalex.org/W2767714545","https://openalex.org/W2768326008","https://openalex.org/W2790717426","https://openalex.org/W2794245536","https://openalex.org/W2805103138","https://openalex.org/W2895723582","https://openalex.org/W2907567208","https://openalex.org/W2934840264","https://openalex.org/W2940338415","https://openalex.org/W4239082087","https://openalex.org/W4248107770","https://openalex.org/W4249672554"],"related_works":["https://openalex.org/W4409289796","https://openalex.org/W4405315316","https://openalex.org/W2209117202","https://openalex.org/W2588812754","https://openalex.org/W4285740847","https://openalex.org/W3165585326","https://openalex.org/W7018695675","https://openalex.org/W3034501534","https://openalex.org/W3001970073","https://openalex.org/W2473925106"],"abstract_inverted_index":{"The":[0],"efficacious":[1],"dose":[2,31,42,44,54,68,94,118],"of":[3,111,125],"a":[4,40,92],"drug":[5,23,37,75,79,89,121],"is":[6,17],"perhaps":[7],"the":[8,29,36,51,112],"most":[9],"holistic":[10],"metric":[11],"reflecting":[12],"its":[13],"therapeutic":[14],"potential.":[15],"Dose":[16,81],"predicted":[18],"at":[19,39,58,83],"many":[20],"stages":[21],"in":[22,46,74],"discovery":[24,76],"and":[25,43,61,96,114,129],"development.":[26,66],"Prior":[27],"to":[28,35,77,101],"1990s,":[30],"prediction":[32,119],"was":[33],"limited":[34],"\"working\"":[38],"reasonable":[41],"regimen":[45,95],"an":[47,109],"animal":[48],"model.":[49],"Through":[50],"early":[52,73],"2000s,":[53],"predictions":[55,69,82],"were":[56],"generated":[57],"candidate":[59],"nomination":[60],"then":[62],"refined":[63],"during":[64],"clinical":[65],"Currently,":[67],"can":[70,86],"be":[71],"made":[72],"enable":[78],"design.":[80,122],"this":[84,105],"stage":[85],"identify":[87],"critical":[88],"properties":[90],"for":[91,120],"viable":[93],"provide":[97],"clinically":[98],"relevant":[99],"context":[100],"lead":[102],"optimization.":[103],"In":[104],"paper,":[106],"we":[107],"give":[108],"overview":[110],"opportunities":[113],"challenges":[115],"associated":[116],"with":[117],"A":[123],"number":[124],"general":[126],"considerations,":[127],"approaches,":[128],"case":[130],"examples":[131],"are":[132],"discussed.":[133]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2999863306","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-01-23T00:00:00"}
